Li Zhao

Multiple drug-resistant HBV mutation may contribute to poor response of adefovir + entecavir in entecavir-resistant patients.

Dongping Xu, Xiaodong Li, Le Li, 2021, Journal of infection in developing countries.

Hepatitis B virus rtA181T/sW172non‐stop mutation may increase resistance fold to adefovir‐ and entecavir‐resistant mutants compared to rtA181T/sW172* mutation

Yan Liu, Yongming Liu, Qi Li, 2018, Antiviral research.

Additional N-glycosylation mutation in the major hydrophilic region of hepatitis B virus S gene is a risk indicator for hepatocellular carcinoma occurrence in patients with coexistence of HBsAg/anti-HBs

Shumei Lin, Zhi-hui Xu, Dongping Xu, 2017, Oncotarget.

Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis.

Wei-min Li, Hao-run Liu, Fang Zheng, 2012, Asian Pacific journal of cancer prevention : APJCP.

Evaluation of methods to eliminate analytical interference in multiple myeloma patients with spurious hyperphosphatemia.

Li Zhao, Yan Liu, Xin Tian, 2023, Laboratoriums Medizin.

Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis.

Wei-min Li, Hao-run Liu, Fang Zheng, 2012, Asian Pacific journal of cancer prevention : APJCP.

Additional N-glycosylation mutation in the major hydrophilic region of hepatitis B virus S gene is a risk indicator for hepatocellular carcinoma occurrence in patients with coexistence of HBsAg/anti-HBs

Zhi-hui Xu, Dongping Xu, Xiaodong Li, 2017, Oncotarget.

Prognostic values of ALDOB expression and 18F-FDG PET/CT in hepatocellular carcinoma

G. Huang, Jianju Liu, Ruixue Zhang, 2022, Frontiers in Oncology.